The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Breast Cancer Metastasis
Open accessAbstract
Despite important progress in adjuvant and neoadjuvant therapies, metastatic disease often develops in breast cancer patients and remains the leading cause of their deaths. For patients with established metastatic disease, therapy is palliative, with few breaks and with mounting adverse effects. Many have hypothesized that a personalized or precision approach (the terms are used interchangeably) to cancer therapy, in which treatment is based on the individual characteristics of each patient, will provide better outcomes. Here, we discuss the molecular basis of breast cancer metastasis and the challenges in personalization of treatment. The instability of metastatic tumors remains a leading obstacle to personalization, because information from a patient's primary tumor may not accurately reflect the metastasis, and one metastasis may vary from another. Furthermore, the variable presence of tumor subpopulations, such as stem cells and dormant cells, may increase the complexity of the targeted treatments needed. Although molecular signatures and circulating biomarkers have been identified in breast cancer, there is lack of validated predictive molecular markers to optimize treatment choices for either prevention or treatment of metastatic disease. Finally, to maximize the information that can be obtained, increased attention to clinical trial design in the metastasis preventive setting is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Self-citationThe Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 2,082
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
The Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Sequence analysis of mutations and translocations across breast cancer subtypes
Banerji, S., Cibulskis, K., Rangel-Escareno, C., Brown, K. K., Carter, S. L., Frederick, A. M., Lawrence, M. S., Sivachenko, A. Y., Sougnez, C., Zou, L., et al. (2012) · Nature · doi:10.1038/nature11154 · Cited by 1,179
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102454108 · Cited by 1,147
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Circulating Tumor Cells: Liquid Biopsy of Cancer
Alix-Panabières, C., & Pantel, K. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.194258 · Cited by 1,134
Parallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2627 · Cited by 1,133
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Howell, A. (1998) · PubMed · Cited by 901
Complex landscapes of somatic rearrangement in human breast cancer genomes
Stephens, P. J., McBride, D. J., Lin, M.-L., Varela, I., Pleasance, E. D., Simpson, J. T., Stebbings, L. A., Leroy, C., Edkins, S., Mudie, L. J., et al. (2009) · Nature · doi:10.1038/nature08645 · Cited by 845
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
Barker, A., Sigman, C., Kelloff, G., Hylton, N., Berry, D., & Esserman, L. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.68 · Cited by 766
Bachelot, T., Romieu, G., Campone, M., Diéras, V., Cropet, C., Dalenc, F., Jimenez, M., Le Rhun, E., Pierga, J.-Y., Gonçalves, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70432-1 · Cited by 737
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
Ebos, J. M. L., & Kerbel, R. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.21 · Cited by 685
Blackwell, K. L., Burstein, H. J., Storniolo, A. M., Rugo, H. S., Sledge, G., Aktan, G., Ellis, C., Florance, A., Vukelja, S., Bischoff, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6725 · Cited by 547
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
Powell, A. A., Talasaz, A. H., Zhang, H., Coram, M. A., Reddy, A., Deng, G., Telli, M. L., Advani, R. H., Carlson, R. W., Mollick, J. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033788 · Cited by 531
Croker, A. K., Goodale, D., Chu, J., Postenka, C., Hedley, B. D., Hess, D. A., & Allan, A. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00455.x · Cited by 525
Inferring tumor progression from genomic heterogeneity
Navin, N., Krasnitz, A., Rodgers, L., Cook, K., Meth, J., Kendall, J., Riggs, M., Eberling, Y., Troge, J., Grubor, V., et al. (2010) · Genome Research · doi:10.1101/gr.099622.109 · Cited by 524
Lindström, L. S., Karlsson, E., Wilking, U. M., Johansson, U., Hartman, J., Lidbrink, E. K., Hatschek, T., Skoog, L., & Bergh, J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2482 · Cited by 523
Metastasis suppressors alter the signal transduction of cancer cells
Steeg, P. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc967 · Cited by 502
Self-citationMolecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 435
Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
Barkan, D., Kleinman, H., Simmons, J. L., Asmussen, H., Kamaraju, A. K., Hoenorhoff, M. J., Liu, Z.-Y., Costes, S. V., Cho, E. H., Lockett, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6849 · Cited by 425
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype
Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj068 · Cited by 423
White, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.025 · Cited by 413
Niikura, N., Liu, J., Hayashi, N., Mittendorf, E. A., Gong, Y., Palla, S. L., Tokuda, Y., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Ueno, N. T. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8889 · Cited by 410
Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Yang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404
Brufsky, A. M., Mayer, M., Rugo, H. S., Kaufman, P. A., Tan-Chiu, E., Tripathy, D., Tudor, I. C., Wang, L. I., Brammer, M. G., Shing, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2962 · Cited by 386
Self-citationKallergi, G., Papadaki, M. A., Politaki, E., Mavroudis, D., Georgoulias, V., & Agelaki, S. (2011) · Breast Cancer Research · doi:10.1186/bcr2896 · Cited by 377
Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
Mehta, R. S., Barlow, W. E., Albain, K. S., Vandenberg, T. A., Dakhil, S. R., Tirumali, N. R., Lew, D. L., Hayes, D. F., Gralow, J. R., Livingston, R. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201622 · Cited by 371
Moody, S. E., Sarkisian, C. J., Hahn, K. T., Gunther, E. J., Pickup, S., Dugan, K. D., Innocent, N., Cardiff, R. D., Schnall, M. D., & Chodosh, L. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00212-x · Cited by 345
Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain
Palmieri, D., Bronder, J. L., Herring, J. M., Yoneda, T., Weil, R. J., Stark, A. M., Kurek, R., Vega-Valle, E., Feigenbaum, L., Halverson, D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3316 · Cited by 333
Self-citationClinical implications of cancer self-seeding
Comen, E., Norton, L., & Massagué, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.64 · Cited by 312
Naumov, G. N., Townson, J. L., MacDonald, I. C., Wilson, S. M., Bramwell, V. H. C., Groom, A. C., & Chambers, A. F. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000004377.12288.3c · Cited by 305
Does tumour dormancy offer a therapeutic target?
Goss, P. E., & Chambers, A. F. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2933 · Cited by 302
Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain
Gril, B., Palmieri, D., Bronder, J. L., Herring, J. M., Vega-Valle, E., Feigenbaum, L., Liewehr, D. J., Steinberg, S. M., Merino, M. J., Rubin, S. D., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn216 · Cited by 283
Self-citationThe predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
Knauer, M., Mook, S., Rutgers, E. J. T., Bender, R. A., Hauptmann, M., van de Vijver, M. J., Koornstra, R. H. T., Bueno-de-Mesquita, J. M., Linn, S. C., & van ’t Veer, L. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0814-2 · Cited by 267
TAILORx: Trial Assigning Individualized Options for Treatment (Rx)
Sparano, J. A. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.051 · Cited by 262
Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1407 · Cited by 249
Yen, L., You, X.-L., Al Moustafa, A.-E., Batist, G., Hynes, N. E., Mader, S., Meloche, S., & Alaoui-Jamali, M. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203685 · Cited by 230
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Jin, K., Teng, L., Shen, Y., He, K., Xu, Z., & Li, G. (2010) · Clinical and Translational Oncology · doi:10.1007/s12094-010-0540-6 · Cited by 217
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
Kim, R. S., Avivar-Valderas, A., Estrada, Y., Bragado, P., Sosa, M. S., Aguirre-Ghiso, J. A., & Segall, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035569 · Cited by 212
Wu, J. M., Fackler, M. J., Halushka, M. K., Molavi, D. W., Taylor, M. E., Teo, W. W., Griffin, C., Fetting, J., Davidson, N. E., De Marzo, A. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4082 · Cited by 202
Pestrin, M., Bessi, S., Galardi, F., Truglia, M., Biggeri, A., Biagioni, C., Cappadona, S., Biganzoli, L., Giannini, A., & Di Leo, A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0461-7 · Cited by 201
Amir, E., Clemons, M., Purdie, C. A., Miller, N., Quinlan, P., Geddie, W., Coleman, R. E., Freedman, O. C., Jordan, L. B., & Thompson, A. M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.006 · Cited by 176
Vlastos, G., Smith, D. L., Singletary, S. E., Mirza, N. Q., Tuttle, T. M., Popat, R. J., Curley, S. A., Ellis, L. M., Roh, M. S., & Vauthey, J.-N. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.01.007 · Cited by 173
Learning therapeutic lessons from metastasis suppressor proteins
Smith, S. C., & Theodorescu, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2594 · Cited by 170
Palmieri, D., Lockman, P. R., Thomas, F. C., Hua, E., Herring, J., Hargrave, E., Johnson, M., Flores, N., Qian, Y., Vega-Valle, E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1039 · Cited by 164
Self-citationRhodes, L. V., Short, S. P., Neel, N. F., Salvo, V. A., Zhu, Y., Elliott, S., Wei, Y., Yu, D., Sun, M., Muir, S. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-3185 · Cited by 154
Marshall, J.-C. A., Collins, J. W., Nakayama, J., Horak, C. E., Liewehr, D. J., Steinberg, S. M., Albaugh, M. E., Vidal‐Vanaclocha, F., Palmieri, D., Barbier, M., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs319 · Cited by 150
Self-citationMehrotra, J., Vali, M., McVeigh, M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0118 · Cited by 143
James, J. J., Evans, A. J., Pinder, S. E., Gutteridge, E., Cheung, K., Chan, S. Y. T., & Robertson, J. F. R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601198 · Cited by 138
Chambers, A. F., Naumov, G. N., Vantyghem, S. A., & Tuck, A. B. (2000) · Breast Cancer Research · doi:10.1186/bcr86 · Cited by 137
Li, J., Karaplis, A. C., Huang, D. C., Siegel, P. M., Camirand, A., Yang, X. F., Muller, W. J., & Kremer, R. B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46134 · Cited by 128
The measurement and therapeutic implications of circulating tumour cells in breast cancer
Smerage, J. B., & Hayes, D. F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602871 · Cited by 124
Nieto, Y. L., Nawaz, S., Jones, R. B., Shpall, E. J., Cagnoni, P. J., McSweeney, P. A., Barón, A. E., Razook, C., Matthes, S., & Bearman, S. I. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.707 · Cited by 122
Should liver metastases of breast cancer be biopsied to improve treatment choice?
Curigliano, G., Bagnardi, V., Viale, G., Fumagalli, L. A. M., Rotmensz, N., Aurilio, G., Locatelli, M., Pruneri, G., Giudici, S., Bellomi, M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq751 · Cited by 117
Ranganathan, A. C., Adam, A. P., Zhang, L., & Aguirre‐Ghiso, J. A. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2968 · Cited by 115
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
Wallwiener, M., Hartkopf, A. D., Baccelli, I., Riethdorf, S., Schott, S., Pantel, K., Marmé, F., Sohn, C., Trumpp, A., Rack, B. K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2382-0 · Cited by 110
Sabnis, G. J., Jelovac, D., Long, B. J., & Brodie, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4092 · Cited by 105
Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.
Oesterreich, S., Deng, W., Jiang, S., Cui, X., Ivanova, M. M., Schiff, R., Kang, K., Hadsell, D. L., Behrens, J., & Lee, A. V. (2003) · PubMed · Cited by 102
Hackshaw, A. K., Roughton, M., Forsyth, S., Monson, K., Reczko, K., Sainsbury, R., & Baum, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2933 · Cited by 102
Functional Mechanisms for Human Tumor Suppressors
Sun, W., & Yang, J. P. (2010) · Journal of Cancer · doi:10.7150/jca.1.136 · Cited by 97
Relevance of PTEN loss in brain metastasis formation in breast cancer patients
Wikman, H., Lamszus, K., Detels, N., Uslar, L., Wrage, M., Benner, C., Hohensee, I., Ylstra, B., Eylmann, K., Zapatka, M., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3150 · Cited by 96
Fitzgerald, D. P., Emerson, D. L., Qian, Y., Anwar, T., Liewehr, D. J., Steinberg, S. M., Silberman, S., Palmieri, D., & Steeg, P. S. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0061 · Cited by 89
Self-citationGril, B., Palmieri, D., Qian, Y., Smart, D. D., Ileva, L. V., Liewehr, D. J., Steinberg, S. M., & Steeg, P. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1603 · Cited by 88
Self-citationLoi, S., Michiels, S., Baselga, J. M., Bartlett, J. M. S., Singhal, S. K., Sabine, V. S., Sims, A. H., Sahmoud, T., Dixon, J. M., Piccart, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053292 · Cited by 85
Heregulin and HER2 signaling selectively activates c‐Src phosphorylation at tyrosine 215
Vadlamudi, R. K., Şahin, A. A., Adam, L., Wang, R., & Kumar, R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00404-6 · Cited by 84
Steeg, P. S. (2012) · Nature · doi:10.1038/485s58a · Cited by 82
Self-citationSinghi, A. D., Cimino‐Mathews, A., Jenkins, R. B., Lan, F., Fink, S. R., Nassar, H., VANG, R. S., Fetting, J. H., Hicks, J. L., Sukumar, S. V., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.171 · Cited by 78
Biology-Driven Phase II Trials: What Is the Optimal Model for Molecular Selection?
André, F., Delaloge, S., & Soria, J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6877 · Cited by 66
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases
Akçakanat, A., Şahin, A. A., Shaye, A. N., Velasco, M. A. D., & Meric‐Bernstam, F. (2008) · Cancer · doi:10.1002/cncr.23456 · Cited by 64
When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene
Chow, A. Y., Arteaga, C. L., & Wang, S. E. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9206-4 · Cited by 56
High frequency of complex TP53 mutations in CNS metastases from breast cancer
Nigro, C. L., Vivenza, D., Monteverde, M., Lattanzio, L., Gojiš, O., Garrone, O., Comino, A., Merlano, M. C., Quinlan, P., Syed, N., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.464 · Cited by 53
New FDA Regulation to Improve Safety Reporting in Clinical Trials
Behrman Sherman, R., Woodcock, J., Norden, J., Grandinetti, C., & Temple, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1103464 · Cited by 50
Niu, G., & Carter, W. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3155 · Cited by 46
Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain
Qian, Y., Hua, E., Bisht, K. S., Woditschka, S., Skordos, K. W., Liewehr, D. J., Steinberg, S. M., Brogi, E., Akram, M. M., Killian, J. K., et al. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9421-9 · Cited by 45
Self-citationDeciphering the molecular basis of breast cancer metastasis with mouse models
Vernon, A. E., Bakewell, S. J., & Chodosh, L. A. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9041-5 · Cited by 34
Khalili, P., Arakelian, A., Chen, G., Singh, G., & Rabbani, S. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208790 · Cited by 29
Frati, A., Chereau, E., Coutant, C., Bézu, C., Antoine, M., Chopier, J., Daraï, É., Uzan, S., Gligorov, J., & Rouzier, R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1897-0 · Cited by 18
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Mechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
Wang, T., Gilkes, D. M., Takano, N., Xiang, L., Luo, W., Bishop, C. J., Chaturvedi, P., Green, J. J., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410041111 · Cited by 493
Breast Cancer Metastasis: Mechanisms and Therapeutic Implications
Park, M., Kim, D., Ko, S., Kim, A., Mo, K., & Yoon, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126806 · Cited by 406
Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016
Golubnitschaja, O., Baban, B., Boniolo, G., Wang, W., Bubnov, R., Kapalla, M., Krapfenbauer, K., Mozaffari, M. S., & Costigliola, V. (2016) · EPMA Journal · doi:10.1186/s13167-016-0072-4 · Cited by 396
Metadata
- Authors
- Marino, N., Woditschka, S., Reed, L. T., Nakayama, J., Mayer, M., Wetzel, M., & Steeg, P. S.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 183
- Issue
- 4
- Pages
- 1084-1095
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W1847015339
- Cited by
- 309
- References
- 104
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.